Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in PMVP — PMV Pharmaceuticals, Inc.

CIK 1107261 HOUSTON, TX
Back to PMVP Full portfolio

Position in PMVP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$574,663
+$42,886 QoQ
Shares Held
428,853
0.0% QoQ
Ownership
0.802%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 64 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PMVP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. PMVP ranks #32 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GLUE
Monte Rosa Therapeutics, Inc.
 552,566 $13,372,097
2 INVA
Innoviva, Inc.
 350,253 $7,954,245
3 PBYI
Puma Biotechnology, Inc.
 791,616 $6,420,005
4 RIGL
Rigel Pharmaceuticals Inc
 124,184 $4,858,078
5 EXEL
Exelixis, Inc.
 66,100 $3,596,501
6 CRMD
CorMedix Inc.
 434,132 $3,407,936
7 KROS
Keros Therapeutics, Inc.
 265,017 $2,835,681
8 PTCT
Ptc Therapeutics, Inc.
 22,000 $1,794,540

All Filings in PMVP

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $574,663 428,853
2026-03-31 $531,777 428,853
2025-12-31 $536,066 428,853
2025-09-30 $448,914 320,653
2025-06-30 $157,728 148,800
2025-03-31 $162,192 148,800
2024-12-31 $305,171 202,100
2024-09-30 $208,451 139,900
2024-06-30 $226,638 139,900
2024-03-31 $127,500 75,000
2023-12-31 $604,190 194,900
2023-09-30 $583,300 95,000
2023-06-30 $594,700 95,000